Related Experiment Video

Updated: Jan 16, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.1K

[Management of MDS according to risk classifications]

Motoshi Ichikawa1

  • 1Department of Hematology, NTT Medical Center Tokyo.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 1, 2025
PubMed
Summary

Myelodysplastic syndromes (MDS) are clonal hematopoietic neoplasms. New classifications and genetic mutation analysis guide risk stratification and personalized treatment strategies for MDS patients.

Keywords:
Gene panel sequencingInternational Consensus ClassificationMyelodysplastic syndromesWHO classification

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.3K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.8K

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K